In Vitro Diagnostics (IVD) Market Expected to Reach $91 Billion by 2027

Pune, Maharashtra, India, September 29 2020 (Wiredrelease) Allied Analytics –:According to a new report published by Allied Market Research, titled, “In Vitro Diagnostics Market by Product & Service, Technique, Application, and End User:  Opportunity Analysis and Industry Forecast, 2020–2026,” the global in vitro diagnostics market size was valued at $67 billion in 2019, and is expected to reach $91 billion by 2027, registering a CAGR of 4.8% from 2020 to 2027.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/336

In vitro diagnostics is defined as medical devices which are used by laboratories to perform diagnostic tests inside a laboratory. These tests are performed on samples collected from a patient’s body such as blood, urine, and tissues. Furthermore, medical devices used to perform in vitro diagnosis also require the use of various technologies to conduct the tests. For instance, blood collected from a patient is analyzed for hepatitis infection by using enzyme linked immunosorbent assay technique to analyze the blood. Furthermore, the testing procedure also requires use of various reagents and the use of software for smooth operations. In addition, in vitro diagnostics are used for detection of various medical conditions such as infectious diseases, diabetes, oncology/cancer, cardiology diseases, autoimmune diseases, nephrology, and HIV/AIDS. Moreover, these tests are performed in various medical facilities such as hospitals, standalone laboratories, and academic & medical schools.

Factors such as rise in awareness about healthcare, surge in incidences of chronic and infectious disease, and cost-effective diagnostic solutions are boost the growth of the in vitro diagnostics market. Similarly, rise in use of automated instruments and point-of-care diagnostic solutions, surge in government expenditure on healthcare globally, and accurate and faster test results supplement the in vitro diagnostics market growth. However, stringent regulations & policies and unclear reimbursement rules hamper the market growth. Moreover, high growth rate exhibited by developing economies are expected to present lucrative opportunities for key players in the in vitro diagnostics market during the forecast period.

The report segments the market across into product & service, technique, application, end user, and region. On the basis of product & service, the market is segmented into reagents, instruments, and services & software. On the basis of technique, it is categorized into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others. In addition, the immunodiagnostics segment is further divided into types such as enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. Moreover, the ELSIA segment is further divided into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Similarly, the molecular diagnostics segment is divided into polymerize chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarray, and others.

The clinical chemistry segment is also further divided basic metabolic panel, liver panel, lipid profile, thyroid function panel, electrolyte panel, specialty chemicals, and others.

On the basis of product & service, the reagents segment acquired the major share of in vitro diagnostics market. The growth of this segment is attributed to the fact that reagents are a vital part of every in-vitro diagnostic test. Hence, the factors aforementioned contribute to the growth of this segment. In addition, the instruments segment is expected to grow at the fastest CAGR during the forecast period, owing to rise in focus of key players toward launching of new instruments.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/336

North America is expected to be the leading regional market for IVD during the forecast period, owing to its well-penetrated healthcare system and higher healthcare awareness among patients, including Obama’s Affordable Care Act (ACA) act, change in technology, and rebounding American Economy. Furthermore, other factors such as easy availability of devices, rise in the awareness related to use of these products and presence of large number of geriatric populations suffering from various chronic diseases also contribute to the growth of the market. Moreover, presence of large number of key players in North America is another major factor that drives the growth of the market. In addition, Asia- Pacific is expected to register fastest growth rate during the forecast period, owing to surge in healthcare expenditure and rise in prevalence of diabetes in the region. Other factors such as huge patient base of other chronic diseases that require IVD testing also boost the growth of market in Asia-Pacific.

Key Findings Of The Study

The reagents segment accounted for more than half of the share of the global in vitro diagnostics market in 2019.

The instruments segment is expected to grow at the highest CAGR from 2020 to 2027.

The infectious diseases segment accounted for around one-thirds share of the global in vitro diagnostics market in 2019.

Europe accounted for around one-fifth share of the global market in 2019.

Asia-Pacific is expected to provide lucrative growth opportunities from 2019 to 2027.

Similar Reports:

Antibiotics Market – Global Opportunity Analysis and Industry Forecast, 2018 – 2025

Predictive Analytics in Healthcare Market -Global Opportunity Analysis and Industry Forecast, 2018 – 2025

Genetic Testing Market – Global Opportunity Analysis and Industry Forecast, 2018 – 2025

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.